UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): January 24, 2012
Illumina, Inc.
(Exact name of registrant as specified in its charter)
| Delaware | 000-30361 | 33-0804655 | ||
| (State or Other Jurisdiction of Incorporation) |
(Commission File Number) |
(I.R.S. Employer Identification No.) | ||
| 5200 Illumina Way, San Diego, California | 92122 | |||
| (Address of principal executive offices) | (Zip Code) | |||
(858) 202-4500
(Registrant’s telephone number, including area code)
Not applicable
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):
| ¨ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| x | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ¨ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ¨ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 8.01. Other Events.
Earlier today, Illumina, Inc. issued a press release relating to the unsolicited proposal received from Roche Holding AG, which is attached as Exhibit 99.1.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
| Exhibit | Description | |
| 99.1 | Press Release, dated January 24, 2012 | |
| 99.2 | Letter to Illumina Employees Concerning Illumina’s Receipt of Unsolicited Proposal from Roche | |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
| Illumina, Inc. | ||
| By: | /s/ Christian G. Cabou | |
| Name: Christian G. Cabou | ||
| Title: Senior Vice President & General Counsel | ||
Date: January 24, 2012
EXHIBIT INDEX
| Exhibit No. |
Description | |
| 99.1 | Press Release, dated January 24, 2012 | |
| 99.2 | Letter to Illumina Employees Concerning Illumina’s Receipt of Unsolicited Proposal from Roche | |